Market Cap 33.91M
Revenue (ttm) 1.13M
Net Income (ttm) -8.40M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -743.36%
Debt to Equity Ratio 0.00
Volume 10,075
Avg Vol 28,370
Day's Range N/A - N/A
Shares Out 33.91M
Stochastic %K 31%
Beta 1.14
Analysts Strong Buy
Price Target $7.00

Company Profile

PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals in the United States. The company's lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. It also provides therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Edina, Minneso...

Industry: Medical Devices
Sector: Healthcare
Phone: 952 405 6216
Address:
5151 Edina Industrial Boulevard, Suite 575, Edina, United States
MadMaverick
MadMaverick Jan. 14 at 8:38 PM
🚨 $PETV is shaping up to be one of the most interesting microcap pet‑health turnarounds on the market! 🔹Regenerative medicine products for pets & horses 🔹Q2 revenue jumped to ~$303K (+51% YoY) 🔹H1 revenue hit $600K+ (+85% YoY) 🔹Total liabilities slashed ~79%, balance sheet the cleanest it’s been in years 🔹OpEx down, losses improving, distributor revenue up 35% YoY Why $PETV stands out: 🔸First international expansion underway (UK + Mexico) 🔸10‑year exclusive pet‑focused AI platform deal targeting next‑gen pet owners 🔸Access to 7,000+ vet clinics through strategic partnerships 🔸New biomaterial R&D combining Spryng with tissue/bone regeneration Still a microcap -- thin liquidity, volatility, and dilution risk remain. But momentum is real: revenue accelerating, costs tightening, and catalysts stacking. Communicated Disclaimer – https://chartingdaily.com/pet-joint-care $CHWY $PET $BARK
0 · Reply
investical
investical Jan. 14 at 7:12 PM
$PETV jumping ship https://www.stocktitan.net/sec-filings/PETV/8-k-pet-vivo-holdings-inc-reports-material-event-7342446ddf3d.html
0 · Reply
jcooptechit
jcooptechit Jan. 14 at 6:13 PM
$PETV Dropped A SaaS Bombshell In Vet Tech PetVivo AI recently launched http://PetVivo.ai, an AI SaaS platform for veterinary clinics that could dramatically change how this company is valued. And the market is huge: 📌 30,000 vet practices in the U.S. 📌 >$150B pet care market 📌 Gross margins: 80–90% (SaaS-level) That’s the kind of unit economics that attracts big money. Communicated - Disclaimer: https://stockresearchtoday.com/better-pet-care-through-joint-therapy-solutions/
0 · Reply
JTE_Theta
JTE_Theta Jan. 14 at 2:31 PM
$PETV- Future of Pet Care Is Here ! And It’s Scaling FAST AgenticPet by Digital Landia just smashed through 1,000+ beta users in 72 hours. Their AI platform isn’t just monitoring pets, it’s detecting stress patterns, diet issues, and behavior changes pet owners never noticed. Add a massive nationwide clinic network and a Web3 powered data economy, and this becomes a category defining play. Key Highlights: •Explosive 72 hour adoption proves real demand •10 year exclusive access to PetVivo’s 8,500 clinics •AI agents running on an $80-110M patent portfolio •Tokenized economy rewards owners + professionals •Early testers are already reporting life changing insights CommunicatedDisclaimer:http://chartingdaily.com/pet-joint-care
0 · Reply
TheRealShortSqueezy
TheRealShortSqueezy Jan. 14 at 2:30 PM
$PETV Just Dropped News 📰 Digital Landia’s AgenticPet surpassed 1,000+ active beta users in under 72 hours, signaling strong demand for AI-powered preventive pet healthcare. Key highlights: 🔸1,000+ beta users onboarded under 72 hours 🔸 Confirms demand for proactive, AI-driven pet health monitoring 🔸 Powered by 10 specialized AI agents (Veterinarian, Behaviorist, Geneticist, Radiologist, etc.) 🔸 Early users report detection of health, stress, and behavioral issues previously unnoticed 🔸 Backed by an exclusive 10-year partnership with PetVivo Holdings 🔸 Partnership provides access to ~8,500 veterinary clinics nationwide Momentum is building and PETV sits at the center of AI-driven preventive pet care. Communicated Disclaimer: https://stockresearchtoday.com/better-pet-care-through-joint-therapy-solutions/ Sector Peers: $ZTS $IDXX $ELAN $PAHC
0 · Reply
Elephanthunter7
Elephanthunter7 Jan. 9 at 7:19 PM
$PETV In early 2026, PetVivo (PETV) is focused on growth in the $39.8 billion pet health market, highlighted by strong Q2 fiscal 2026 revenue growth, expansion of their Spryng injection for osteoarthritis, and the launch of an AI platform (PetVivo.ai) for vet practices. The company saw record revenue for its Q2 (ending Sept 30, 2025) with 51% growth, expanding its distributor network and establishing international partnerships, while also moving to the OTCQX market and planning a full launch of PrecisePRP.
0 · Reply
investical
investical Jan. 9 at 6:49 PM
0 · Reply
Elephanthunter7
Elephanthunter7 Jan. 7 at 1:43 PM
$PETV Breakout coming !! https://biotuesdays.com/2026/01/06/petvivo-improving-the-lives-of-pets-and-athlete-animals-through-joint-health-and-mobility/
0 · Reply
Elephanthunter7
Elephanthunter7 Jan. 7 at 1:41 PM
$PETV Our B2C partner just launched their beta test and we got invite codes to share with you! Want to try the AI agents before anyone else? This is your chance to test the same technology that will power http://PetVivo.ai when we launch Q1 2026. Check it out 👇 https://x.com/AgenticPet/status/2008620797250666973?s=20
0 · Reply
investical
investical Jan. 7 at 1:31 PM
0 · Reply
Latest News on PETV
No data available.
MadMaverick
MadMaverick Jan. 14 at 8:38 PM
🚨 $PETV is shaping up to be one of the most interesting microcap pet‑health turnarounds on the market! 🔹Regenerative medicine products for pets & horses 🔹Q2 revenue jumped to ~$303K (+51% YoY) 🔹H1 revenue hit $600K+ (+85% YoY) 🔹Total liabilities slashed ~79%, balance sheet the cleanest it’s been in years 🔹OpEx down, losses improving, distributor revenue up 35% YoY Why $PETV stands out: 🔸First international expansion underway (UK + Mexico) 🔸10‑year exclusive pet‑focused AI platform deal targeting next‑gen pet owners 🔸Access to 7,000+ vet clinics through strategic partnerships 🔸New biomaterial R&D combining Spryng with tissue/bone regeneration Still a microcap -- thin liquidity, volatility, and dilution risk remain. But momentum is real: revenue accelerating, costs tightening, and catalysts stacking. Communicated Disclaimer – https://chartingdaily.com/pet-joint-care $CHWY $PET $BARK
0 · Reply
investical
investical Jan. 14 at 7:12 PM
$PETV jumping ship https://www.stocktitan.net/sec-filings/PETV/8-k-pet-vivo-holdings-inc-reports-material-event-7342446ddf3d.html
0 · Reply
jcooptechit
jcooptechit Jan. 14 at 6:13 PM
$PETV Dropped A SaaS Bombshell In Vet Tech PetVivo AI recently launched http://PetVivo.ai, an AI SaaS platform for veterinary clinics that could dramatically change how this company is valued. And the market is huge: 📌 30,000 vet practices in the U.S. 📌 >$150B pet care market 📌 Gross margins: 80–90% (SaaS-level) That’s the kind of unit economics that attracts big money. Communicated - Disclaimer: https://stockresearchtoday.com/better-pet-care-through-joint-therapy-solutions/
0 · Reply
JTE_Theta
JTE_Theta Jan. 14 at 2:31 PM
$PETV- Future of Pet Care Is Here ! And It’s Scaling FAST AgenticPet by Digital Landia just smashed through 1,000+ beta users in 72 hours. Their AI platform isn’t just monitoring pets, it’s detecting stress patterns, diet issues, and behavior changes pet owners never noticed. Add a massive nationwide clinic network and a Web3 powered data economy, and this becomes a category defining play. Key Highlights: •Explosive 72 hour adoption proves real demand •10 year exclusive access to PetVivo’s 8,500 clinics •AI agents running on an $80-110M patent portfolio •Tokenized economy rewards owners + professionals •Early testers are already reporting life changing insights CommunicatedDisclaimer:http://chartingdaily.com/pet-joint-care
0 · Reply
TheRealShortSqueezy
TheRealShortSqueezy Jan. 14 at 2:30 PM
$PETV Just Dropped News 📰 Digital Landia’s AgenticPet surpassed 1,000+ active beta users in under 72 hours, signaling strong demand for AI-powered preventive pet healthcare. Key highlights: 🔸1,000+ beta users onboarded under 72 hours 🔸 Confirms demand for proactive, AI-driven pet health monitoring 🔸 Powered by 10 specialized AI agents (Veterinarian, Behaviorist, Geneticist, Radiologist, etc.) 🔸 Early users report detection of health, stress, and behavioral issues previously unnoticed 🔸 Backed by an exclusive 10-year partnership with PetVivo Holdings 🔸 Partnership provides access to ~8,500 veterinary clinics nationwide Momentum is building and PETV sits at the center of AI-driven preventive pet care. Communicated Disclaimer: https://stockresearchtoday.com/better-pet-care-through-joint-therapy-solutions/ Sector Peers: $ZTS $IDXX $ELAN $PAHC
0 · Reply
Elephanthunter7
Elephanthunter7 Jan. 9 at 7:19 PM
$PETV In early 2026, PetVivo (PETV) is focused on growth in the $39.8 billion pet health market, highlighted by strong Q2 fiscal 2026 revenue growth, expansion of their Spryng injection for osteoarthritis, and the launch of an AI platform (PetVivo.ai) for vet practices. The company saw record revenue for its Q2 (ending Sept 30, 2025) with 51% growth, expanding its distributor network and establishing international partnerships, while also moving to the OTCQX market and planning a full launch of PrecisePRP.
0 · Reply
investical
investical Jan. 9 at 6:49 PM
0 · Reply
Elephanthunter7
Elephanthunter7 Jan. 7 at 1:43 PM
$PETV Breakout coming !! https://biotuesdays.com/2026/01/06/petvivo-improving-the-lives-of-pets-and-athlete-animals-through-joint-health-and-mobility/
0 · Reply
Elephanthunter7
Elephanthunter7 Jan. 7 at 1:41 PM
$PETV Our B2C partner just launched their beta test and we got invite codes to share with you! Want to try the AI agents before anyone else? This is your chance to test the same technology that will power http://PetVivo.ai when we launch Q1 2026. Check it out 👇 https://x.com/AgenticPet/status/2008620797250666973?s=20
0 · Reply
investical
investical Jan. 7 at 1:31 PM
0 · Reply
jcooptechit
jcooptechit Jan. 6 at 4:55 PM
$PETV Path From A $45M Market Cap To A $1.3B SaaS Powerhouse PetVivo isn't a "concept." It has a massive, clinical-grade footprint. The valuation gap is closing fast as the Q1 SaaS pivot begins. THE FOUNDATION: 🔹 SPRYNG & PrecisePRP (FDA-approved regenerative devices). 🔹 1,200+ clinics active; 7,300+ vets in the distribution network. 🔹 Q2 revenue surged +51% YoY, reaching record levels. 🔹 Strategic partnership with PiezoBioMembrane to develop next-gen, bioelectric nanofibers that mimic natural cartilage. This is exactly how multi-baggers are born. Smart money positions early. Retail chases later. Communicated - Disclaimer: https://chartingdaily.com/pet-joint-care
0 · Reply
TheRealShortSqueezy
TheRealShortSqueezy Jan. 6 at 2:35 PM
$PETV : From Vet Devices to AI Powerhouse 🐾 PetVivo Holdings develops FDA approved regenerative veterinary devices and is now leveraging its installed base to launch a high-margin AI diagnostic platform. The foundation➡️ The Device Business: ➖ SPRYNG & PrecisePRP FDA-approved regenerative veterinary devices ➖1,000+ veterinary clinics actively using PetVivo products ➖7,300+ veterinarians in the distribution network ➖30% gross margins with stable, repeat revenue The Catalyst ➡️The AI Platform: ➖ http://PetVivo.ai launching Q1 2026 (≈ 90 days away) ➖ 10 specialized AI diagnostic agents ➖ 80–90% gross margins, a massive step-change from devices The market opportunity: Wall Street is valuing PetVivo as a low multiple veterinary device company (~$45M market cap), while the company is evolving into an AI-driven platform that could justify a $360M$1.35B+ valuation. Communicated Disclaimer: https://stockresearchtoday.com/better-pet-care-through-joint-therapy-solutions/ Sector Peers: $ZTS $IDXX $ELAN $PAHC
1 · Reply
BioTuesdays
BioTuesdays Jan. 6 at 2:16 PM
$PETV is adapting human regenerative therapies for the management of osteoarthritis (OA) and other joint disorders in companion and athlete animals. The company’s proprietary platform includes a pipeline of biomaterial-based products highlighted by its breakthrough intra-articular injectable veterinary medical device—Spryng with OsteoCushion Technology. https://biotuesdays.com/2026/01/06/petvivo-improving-the-lives-of-pets-and-athlete-animals-through-joint-health-and-mobility/
0 · Reply
Elephanthunter7
Elephanthunter7 Jan. 6 at 3:30 AM
$PETV PetVivo Holdings, Inc. @PetVivo This is huge! 🎉 Proud to be partnered with @AgenticPet and the @DigitalLandia team. Their innovation continues to push the boundaries of what's possible with AI-powered healthcare. This announcement validates everything we've been building together for the veterinary space. Q1 2026 is going to be incredible
0 · Reply
investical
investical Jan. 5 at 8:55 PM
$PETV “The third parties paying for our services, the profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to impact share prices, possibly significantly.”
0 · Reply
MadMaverick
MadMaverick Jan. 5 at 8:44 PM
0 · Reply
MadMaverick
MadMaverick Jan. 5 at 8:44 PM
🚨 $PETV is gaining attention as demand rises for next‑gen veterinary therapeutics! 🔹Commercializing a regenerative, sustained‑release joint therapy for animals 🔹Growing demand for non‑drug, biomaterial‑based pain solutions 🔹Reported 78%+ gross margins with expanding clinic adoption 🔹Visibility rising after DealFlow presentation and new outreach initiatives Watching for a reclaim of $1.20 to confirm accumulation and early trend reversal Communicated Disclaimer - https://chartingdaily.com/pet-joint-care
0 · Reply
BullTradeFinder
BullTradeFinder Jan. 5 at 8:00 PM
$PETV is setting up for a margin-driven re-rating • FDA-approved SPRYNG® and PrecisePRP® • 1,000+ active veterinary clinics • 7,300+ vets in distribution network • ~30% gross margins funding expansion • PiezoBioMembrane partnership builds long-term IP moat The Valuation Changer: • http://PetVivo.ai launches Q1 2026 • 10 AI diagnostic agents built specifically for veterinarians • B2B SaaS model: Free | $199 | $499 • 80–90% gross margins • Beta results show 95–98% CAC reduction for clinics This is not just a device company. It’s a transition from hardware margins to software margins. Communicated-Disclaimer https://chartingdaily.com/pet-joint-care
0 · Reply
BullTradeFinder
BullTradeFinder Jan. 5 at 7:59 PM
$PETV is setting up for a margin-driven re-rating • FDA-approved SPRYNG® and PrecisePRP® • 1,000+ active veterinary clinics • 7,300+ vets in distribution network • ~30% gross margins funding expansion • PiezoBioMembrane partnership builds long-term IP moat The Valuation Changer: • PetVivo.ai launches Q1 2026 • 10 AI diagnostic agents built specifically for veterinarians • B2B SaaS model: Free | $199 | $499 • 80–90% gross margins • Beta results show 95–98% CAC reduction for clinics This is not just a device company. It’s a transition from hardware margins to software margins. Communicated-Disclaimer https://chartingdaily.com/pet-joint-care
0 · Reply
Giants67
Giants67 Jan. 5 at 2:05 PM
$PETV Digital Landia Launches AgenticPet Public Beta, Announces Web3 Integration Coming in Weeks as 2026 Emerges as "Year of Tokenization" Beta live now; blockchain payments launching soon as regulatory momentum builds for digital assets https://www.accessnewswire.com/newsroom/en/blockchain-and-cryptocurrency/digital-landia-launches-agenticpet-public-beta-announces-web3-integra-1123882
0 · Reply
investical
investical Jan. 5 at 1:20 AM
0 · Reply
Elephanthunter7
Elephanthunter7 Jan. 5 at 12:42 AM
$PETV Breakout stock of 2026 As of January 4, 2026, (OTCQX: PETV)has officially opened pre-launch registration for its new artificial intelligence platform. Strategic Shift to SaaS: The launch of Petvivo.ai marks the company's transition from a medical device manufacturer to a high-margin Software as a Service (SaaS) model. AgenticPet Framework: The platform utilizes the "AgenticPet" AI framework, developed under an exclusive 10-year licensing agreement with Digital Landia Holding Corp. This framework includes five patent-pending innovations, such as swarm-intelligence coordination and privacy-preserving health-data synthesis. Operational Benefits: The AI is designed to reduce veterinary client acquisition costs by 50% to 90% and assist in real-time monitoring and predictive analysis for clinics. Market Targets: The company is targeting 30,000 U.S. veterinary practices with projected growth reaching 5,000 practices and $180M in Annual Recurring Revenue (ARR)
0 · Reply